Galectin Therapeutics
GALT
#8296
Rank
โ‚ฌ0.28 B
Marketcap
2,85ย โ‚ฌ
Share price
-5.62%
Change (1 day)
-35.06%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2026 (TTM): -โ‚ฌ24 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ27.53 Million, an increase over its 2024 earnings that were of -โ‚ฌ42 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ24 Million-12.82%
2025 -โ‚ฌ27.53 Million-34.46%
2024 -โ‚ฌ42 Million14.56%
2023 -โ‚ฌ36.66 Million5.91%
2022 -โ‚ฌ34.62 Million27.02%
2021 -โ‚ฌ27.26 Million30.1%
2020 -โ‚ฌ20.95 Million76.51%
2019 -โ‚ฌ11.87 Million-4.36%
2018 -โ‚ฌ12.41 Million-14.38%
2017 -โ‚ฌ14.5 Million-24.26%
2016 -โ‚ฌ19.14 Million7.04%
2015 -โ‚ฌ17.88 Million26.85%
2014 -โ‚ฌ14.1 Million30.61%
2013 -โ‚ฌ10.8 Million27.82%
2012 -โ‚ฌ8.45 Million-9.15%
2011 -โ‚ฌ9.3 Million113.17%
2010 -โ‚ฌ4.36 Million-19.86%
2009 -โ‚ฌ5.44 Million14.4%
2008 -โ‚ฌ4.76 Million-17.49%
2007 -โ‚ฌ5.77 Million-8.41%
2006 -โ‚ฌ6.3 Million5.91%
2005 -โ‚ฌ5.95 Million-8.89%
2004 -โ‚ฌ6.53 Million47.92%
2003 -โ‚ฌ4.41 Million50.22%
2002 -โ‚ฌ2.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Mirati Therapeutics
MRTX
-โ‚ฌ0.69 Billion 2,647.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚ฌ43.44 Million 74.74%๐Ÿ‡บ๐Ÿ‡ธ USA